Generation of Cancer Stem/Initiating Cells by Cell-Cell Fusion.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Apr 2022
Historique:
received: 21 03 2022
revised: 10 04 2022
accepted: 17 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

CS/ICs have raised great expectations in cancer research and therapy, as eradication of this key cancer cell type is expected to lead to a complete cure. Unfortunately, the biology of CS/ICs is rather complex, since no common CS/IC marker has yet been identified. Certain surface markers or ALDH1 expression can be used for detection, but some studies indicated that cancer cells exhibit a certain plasticity, so CS/ICs can also arise from non-CS/ICs. Another problem is intratumoral heterogeneity, from which it can be inferred that different CS/IC subclones must be present in the tumor. Cell-cell fusion between cancer cells and normal cells, such as macrophages and stem cells, has been associated with the generation of tumor hybrids that can exhibit novel properties, such as an enhanced metastatic capacity and even CS/IC properties. Moreover, cell-cell fusion is a complex process in which parental chromosomes are mixed and randomly distributed among daughter cells, resulting in multiple, unique tumor hybrids. These, if they have CS/IC properties, may contribute to the heterogeneity of the CS/IC pool. In this review, we will discuss whether cell-cell fusion could also lead to the origin of different CS/ICs that may expand the overall CS/IC pool in a primary tumor.

Identifiants

pubmed: 35562905
pii: ijms23094514
doi: 10.3390/ijms23094514
pmc: PMC9101717
pii:
doi:

Substances chimiques

Biomarkers 0
Aldehyde Dehydrogenase 1 Family EC 1.2.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Genes Dev. 2001 Jan 1;15(1):50-65
pubmed: 11156605
Adv Exp Med Biol. 2011;713:33-64
pubmed: 21432013
Commun Integr Biol. 2012 Sep 1;5(5):511-5
pubmed: 23739834
PLoS One. 2011 Jan 14;6(1):e16186
pubmed: 21264259
Science. 2017 Apr 21;356(6335):323-327
pubmed: 28386024
Nature. 2012 Aug 23;488(7412):522-6
pubmed: 22854781
Dev Cell. 2018 Sep 24;46(6):767-780.e7
pubmed: 30197239
PLoS One. 2012;7(8):e42653
pubmed: 22880071
Am J Pathol. 2015 Jul;185(7):2049-60
pubmed: 26066710
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
Nature. 2008 Dec 4;456(7222):593-8
pubmed: 19052619
Prostate. 2020 Feb;80(3):274-283
pubmed: 31846114
Development. 2019 Mar 19;146(6):
pubmed: 30683662
Int J Oncol. 2013 Aug;43(2):425-30
pubmed: 23708747
Int J Mol Sci. 2016 Jun 21;17(6):
pubmed: 27338362
Nature. 1974 Aug 23;250(5468):649-51
pubmed: 4859359
Nat Cell Biol. 2008 May;10(5):575-83
pubmed: 18425116
Bone Marrow Transplant. 2004 Jul;34(2):183-6
pubmed: 15195072
Front Immunol. 2020 Aug 07;11:1280
pubmed: 32849491
Int J Mol Sci. 2020 Mar 06;21(5):
pubmed: 32155721
Cancer Sci. 2011 Oct;102(10):1774-81
pubmed: 21740477
Biol Reprod. 2019 Feb 1;100(2):390-397
pubmed: 30304517
J Clin Invest. 2004 May;113(9):1266-70
pubmed: 15124017
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63
pubmed: 17548814
Nature. 2002 Apr 4;416(6880):485-7
pubmed: 11932725
J Cell Sci. 2009 Feb 15;122(Pt 4):453-9
pubmed: 19155290
Genes (Basel). 2020 Nov 20;11(11):
pubmed: 33233552
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Haematologica. 2019 Jul;104(7):1388-1395
pubmed: 30630989
PLoS One. 2009 Aug 06;4(8):e6530
pubmed: 19657387
J Pathol. 2013 Jan;229(2):176-85
pubmed: 23096265
J Mol Biol. 2009 Sep 18;392(2):301-18
pubmed: 19616006
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Elife. 2020 Nov 25;9:
pubmed: 33236985
Front Oncol. 2015 Jul 20;5:155
pubmed: 26258068
Cell. 2014 Apr 10;157(2):407-419
pubmed: 24725407
Acta Neuropathol. 2018 Jun;135(6):907-921
pubmed: 29541917
Stem Cells. 2018 Jul;36(7):977-989
pubmed: 29569804
Pathobiology. 2012;79(4):195-208
pubmed: 22488297
PLoS One. 2013 Jun 26;8(6):e66731
pubmed: 23840523
Int J Mol Med. 2016 Oct;38(4):979-86
pubmed: 27599669
J Immunol. 1997 Apr 1;158(7):3385-90
pubmed: 9120298
BJOG. 2006 Feb;113(2):152-8
pubmed: 16411991
Cell Mol Life Sci. 2020 Apr;77(8):1551-1569
pubmed: 31642939
Mol Cancer. 2017 Feb 16;16(1):41
pubmed: 28209166
Br J Haematol. 2010 Feb;148(4):551-61
pubmed: 19919653
Am J Pathol. 2012 Jun;180(6):2504-15
pubmed: 22542847
Cancer Res. 2007 May 15;67(10):4827-33
pubmed: 17510412
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7353-7362
pubmed: 30910979
Int J Cancer. 2009 Oct 15;125(8):1826-31
pubmed: 19582880
PLoS One. 2012;7(7):e41942
pubmed: 22848668
J Mol Med (Berl). 2007 Jan;85(1):23-38
pubmed: 17066266
PLoS One. 2013 May 07;8(5):e63711
pubmed: 23667660
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
pubmed: 12629218
Br J Cancer. 1992 Apr;65(4):529-37
pubmed: 1562463
Nat Med. 2004 Jul;10(7):744-8
pubmed: 15195088
Physiol Rev. 2016 Apr;96(2):605-45
pubmed: 26936867
Cancer Res. 2006 Aug 15;66(16):8274-9
pubmed: 16912208
Cancer Res. 2003 Sep 15;63(18):5821-8
pubmed: 14522905
Cell Stem Cell. 2011 Oct 4;9(4):357-65
pubmed: 21982235
Nature. 2000 Feb 17;403(6771):785-9
pubmed: 10693809
Nat Rev Cancer. 2008 May;8(5):377-86
pubmed: 18385683
Mol Cell Biol. 1983 Apr;3(4):523-38
pubmed: 6687920
Anticancer Res. 2016 Aug;36(8):3827-31
pubmed: 27466484
Cell Cycle. 2015;14(17):2810-20
pubmed: 26151317
Development. 2012 Feb;139(4):641-56
pubmed: 22274696
Nature. 2007 Jan 4;445(7123):111-5
pubmed: 17122771
Nat Cell Biol. 2019 Jan;21(1):54-62
pubmed: 30602769
BMC Cancer. 2015 Nov 20;15:922
pubmed: 26585897
J Cell Biochem. 2007 May 1;101(1):122-34
pubmed: 17171644
J Biol Chem. 2021 Jan-Jun;296:100411
pubmed: 33581114
Nat Cell Biol. 2013 Apr;15(4):338-44
pubmed: 23548926
Nature. 2005 Mar 10;434(7030):234-8
pubmed: 15759005
Curr Biol. 2020 Jul 6;30(13):R750-R754
pubmed: 32634411
Sci Rep. 2020 Jan 27;10(1):1216
pubmed: 31988304
Cell Mol Immunol. 2021 Mar;18(3):579-587
pubmed: 32934339
PLoS One. 2012;7(3):e33358
pubmed: 22428030
Cells. 2021 Jun 11;10(6):
pubmed: 34207991
J Leukoc Biol. 2009 Apr;85(4):617-26
pubmed: 19141565
J Cell Biol. 2012 May 14;197(4):553-68
pubmed: 22584907
Stem Cell Reports. 2013 Dec 27;2(1):78-91
pubmed: 24511467
Nat Med. 1997 Jul;3(7):730-7
pubmed: 9212098
J Vis Exp. 2012 Jan 04;(59):e3581
pubmed: 22230968
Cell. 2003 May 16;113(4):483-94
pubmed: 12757709
Trends Cell Biol. 2015 Nov;25(11):639-650
pubmed: 26437594
Tumour Biol. 2016 Apr;37(4):5025-30
pubmed: 26537586
FEBS J. 2014 Nov;281(21):4779-91
pubmed: 25158828
Cancer Res. 2005 Jul 15;65(14):6207-19
pubmed: 16024622
FEBS J. 2016 Mar;283(5):791-802
pubmed: 26555863
Bone Marrow Transplant. 2005 May;35(10):1021-4
pubmed: 15778726
Nat Rev Cancer. 2005 Nov;5(11):899-904
pubmed: 16327766
Neoplasia. 2012 Nov;14(11):1057-66
pubmed: 23226099
Cell Mol Life Sci. 2015 Oct;72(19):3769-82
pubmed: 25900663
Cancer Res. 2013 Sep 1;73(17):5360-70
pubmed: 23856249
Sci Adv. 2020 May 06;6(19):eaba0310
pubmed: 32494719
Oncotarget. 2016 May 10;7(19):27067-84
pubmed: 27008704
Cell Cycle. 2019 Feb;18(3):320-332
pubmed: 30636489
PLoS One. 2017 Sep 28;12(9):e0184451
pubmed: 28957348
Cell Res. 2007 Jan;17(1):3-14
pubmed: 17179981
Cancers (Basel). 2021 Sep 06;13(17):
pubmed: 34503305
Contrib Microbiol. 2006;13:138-155
pubmed: 16627963
J Pathol. 2007 Jan;211(1):10-7
pubmed: 17083146
BMC Cancer. 2015 Jan 30;15:24
pubmed: 25633122
Oncol Rep. 2013 Feb;29(2):713-9
pubmed: 23232668
Curr Top Membr. 2011;68:235-58
pubmed: 21771502
Blood. 2001 May 15;97(10):3283-91
pubmed: 11342460
PLoS One. 2015 Mar 17;10(3):e0121468
pubmed: 25781974
Nat Commun. 2016 Jul 15;7:12198
pubmed: 27416963
Cell Stem Cell. 2007 Nov;1(5):555-67
pubmed: 18371393
PLoS One. 2014 Feb 06;9(2):e87893
pubmed: 24516569
Front Cell Dev Biol. 2022 Feb 01;9:809668
pubmed: 35178400
Adv Exp Med Biol. 2011;713:161-75
pubmed: 21432019
Biol Reprod. 2014 Jun;90(6):117
pubmed: 24740598
Oncotarget. 2017 May 18;8(31):51370-51386
pubmed: 28881654
Cancer Genet. 2021 Aug;256-257:162-164
pubmed: 34166887
PLoS One. 2013;8(1):e55572
pubmed: 23383228
PLoS One. 2015 Aug 12;10(8):e0134320
pubmed: 26267609
Curr Biol. 2011 Feb 8;21(3):R121-3
pubmed: 21300277
Annu Rev Cell Dev Biol. 2014;30:111-39
pubmed: 25000995
PLoS Genet. 2009 Feb;5(2):e1000385
pubmed: 19229314
Nature. 2010 Jul 1;466(7302):133-7
pubmed: 20596026
J Histochem Cytochem. 1999 Jan;47(1):65-74
pubmed: 9857213
Med Hypotheses. 2009 Oct;73(4):542-7
pubmed: 19564079
Arch Immunol Ther Exp (Warsz). 2008 May-Jun;56(3):165-80
pubmed: 18512024
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Cell Death Dis. 2016 Jul 28;7(7):e2314
pubmed: 27468690
Cancer Res. 2007 May 1;67(9):4010-5
pubmed: 17483311
Curr Biol. 2015 May 18;25(10):R397-9
pubmed: 25989073
Cancer Cell. 2010 Nov 16;18(5):510-23
pubmed: 21075313
Clin Exp Metastasis. 1996 Mar;14(2):95-106
pubmed: 8605733
Cancer Res. 2005 Dec 1;65(23):10946-51
pubmed: 16322242
J Thorac Oncol. 2020 Sep;15(9):1460-1471
pubmed: 32416323
Nature. 2013 Jul 18;499(7458):301-5
pubmed: 23868259
Nat Rev Mol Cell Biol. 2009 Jul;10(7):478-87
pubmed: 19546858
Cell Rep. 2015 Jun 16;11(10):1549-63
pubmed: 26051943
Development. 2017 Dec 15;144(24):4481-4495
pubmed: 29254991
Oncogene. 2020 May;39(21):4198-4211
pubmed: 32242148
J Cell Biol. 2010 Nov 29;191(5):1013-27
pubmed: 21098115
Clin Exp Metastasis. 1998 May;16(4):299-312
pubmed: 9626809
Theranostics. 2020 Jul 9;10(19):8721-8743
pubmed: 32754274
Nature. 2010 Oct 7;467(7316):707-10
pubmed: 20861837
Cancer Res. 2009 Nov 15;69(22):8536-9
pubmed: 19887616
Nat Rev Cancer. 2013 Oct;13(10):727-38
pubmed: 24060864
J Cell Biol. 2019 May 6;218(5):1436-1451
pubmed: 30936162
Front Immunol. 2021 Jan 14;11:607328
pubmed: 33519817
Science. 2012 Aug 10;337(6095):730-5
pubmed: 22855427
Oncogene. 2013 May 23;32(21):2649-60
pubmed: 22751128
Cancer Res. 2011 Feb 15;71(4):1497-505
pubmed: 21303980
Front Biosci. 2008 Jan 01;13:453-61
pubmed: 17981560
Hum Pathol. 2007 May;38(5):726-31
pubmed: 17306327
PLoS One. 2008 Aug 06;3(8):e2888
pubmed: 18682804
Cancers (Basel). 2021 Oct 26;13(21):
pubmed: 34771528
Trends Cell Biol. 2017 Dec;27(12):917-930
pubmed: 28899600
Nature. 2000 Jul 20;406(6793):257
pubmed: 10917519
Sci Rep. 2016 Nov 09;6:36863
pubmed: 27827439
Curr Opin Genet Dev. 2003 Oct;13(5):480-5
pubmed: 14550412
Cancer Res. 2007 Apr 1;67(7):3153-61
pubmed: 17409422
Br J Cancer. 2010 Mar 2;102(5):815-26
pubmed: 20145614
FASEB J. 2015 Sep;29(9):4036-45
pubmed: 26085132
Int J Cancer. 2008 Aug 15;123(4):780-6
pubmed: 18506688
J Cell Biol. 2005 Nov 7;171(3):493-503
pubmed: 16275753
Cell Biol Int. 1994 Mar;18(3):207-10
pubmed: 8019495
Cell Stem Cell. 2007 Sep 13;1(3):313-23
pubmed: 18371365
Cancer Lett. 2010 May 28;291(2):150-7
pubmed: 19913993
Nat Rev Cancer. 2013 Feb;13(2):97-110
pubmed: 23344542
Cancers (Basel). 2019 Feb 05;11(2):
pubmed: 30764554
BMC Cancer. 2017 Aug 2;17(1):515
pubmed: 28768501
Cancer Res. 2010 Jun 1;70(11):4624-33
pubmed: 20484027
Oncol Rep. 2010 May;23(5):1375-82
pubmed: 20372854
Oncol Rep. 2014 Aug;32(2):539-47
pubmed: 24926698
Stem Cells Dev. 2015 Nov 1;24(21):2467-78
pubmed: 26192559
Nature. 1994 Feb 17;367(6464):645-8
pubmed: 7509044
Mol Cancer Res. 2019 Mar;17(3):806-820
pubmed: 30587522
Nat Commun. 2019 Oct 1;10(1):4456
pubmed: 31575859
Sci Rep. 2020 Dec 10;10(1):21634
pubmed: 33303824
Eur J Immunol. 2007 Jan;37(1):33-42
pubmed: 17154265
Sci Adv. 2018 Sep 12;4(9):eaat7828
pubmed: 30214939
Cancer Res. 2006 Oct 1;66(19):9339-44
pubmed: 16990346
Dev Cell. 2015 Mar 9;32(5):561-73
pubmed: 25684354
Semin Cancer Biol. 2022 Jun;81:24-36
pubmed: 33727077
Biol Reprod. 2010 Sep;83(3):387-95
pubmed: 20484742
Nature. 2012 Aug 23;488(7412):527-30
pubmed: 22854777
Cancers (Basel). 2019 Sep 25;11(10):
pubmed: 31557960
Breast Cancer Res. 2008;10(1):R10
pubmed: 18241344
Int J Cancer. 2008 Feb 15;122(4):761-8
pubmed: 17955491
J Cell Sci. 2007 Feb 15;120(Pt 4):670-81
pubmed: 17264150
PLoS One. 2012;7(7):e41052
pubmed: 22829910
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2337-E2346
pubmed: 28270621
Nat Cell Biol. 2008 May;10(5):584-92
pubmed: 18425115
FEBS Lett. 2005 Jul 18;579(18):3991-8
pubmed: 16004993
Nature. 2003 Oct 30;425(6961):968-73
pubmed: 14555960
Exp Cell Res. 2012 Aug 15;318(14):1707-15
pubmed: 22664325
Nat Ecol Evol. 2021 Mar;5(3):379-391
pubmed: 33462489
Nature. 2007 Jan 4;445(7123):106-10
pubmed: 17122772
Stem Cells Dev. 2015 Apr 15;24(8):1008-21
pubmed: 25519836
Nat Cell Biol. 2018 Jun;20(6):688-698
pubmed: 29802406
J Invest Dermatol. 2012 Oct;132(10):2440-2450
pubmed: 22622430
Cell Stem Cell. 2014 Mar 6;14(3):275-91
pubmed: 24607403
Mol Cancer. 2006 Dec 02;5:67
pubmed: 17140455
J Clin Invest. 2008 Jun;118(6):2111-20
pubmed: 18497886
PLoS One. 2017 Feb 1;12(2):e0168581
pubmed: 28146572
PLoS One. 2015 May 28;10(5):e0126522
pubmed: 26020648
Nature. 2011 Dec 07;481(7379):85-9
pubmed: 22158103
Adv Exp Med Biol. 2011;713:97-111
pubmed: 21432016
Oncogene. 2019 Aug;38(33):6083-6094
pubmed: 31270395
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12921-6
pubmed: 18728192
Vestn Akad Med Nauk SSSR. 1971;26(4):75-80
pubmed: 4327421
Oncotarget. 2016 May 24;7(21):30924-34
pubmed: 27129157
Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):148-157
pubmed: 30587589
Int J Mol Sci. 2020 Mar 09;21(5):
pubmed: 32182935
Birth Defects Res C Embryo Today. 2003 Aug;69(3):209-18
pubmed: 14671774
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6321-5
pubmed: 16606845
Cell Commun Signal. 2018 Jan 5;16(1):2
pubmed: 29329589
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Int J Biochem Cell Biol. 2005 Jan;37(1):1-16
pubmed: 15381142
BMC Cancer. 2016 Feb 04;16:56
pubmed: 26846780
Nat Rev Cancer. 2021 May;21(5):325-338
pubmed: 33547455
Cancer Cell. 2003 May;3(5):445-8
pubmed: 12781362
Biophys J. 2012 Nov 7;103(9):2011-20
pubmed: 23199929
Am J Pathol. 2011 May;178(5):2311-21
pubmed: 21514443
Int J Mol Sci. 2020 Dec 17;21(24):
pubmed: 33348862
Nature. 2003 Apr 24;422(6934):901-4
pubmed: 12665833
Science. 2013 Apr 19;340(6130):359-63
pubmed: 23470732
J Cell Physiol. 2019 Apr;234(4):3570-3582
pubmed: 30417342
Cell Commun Signal. 2018 Apr 10;16(1):14
pubmed: 29636110
Nature. 2013 May 9;497(7448):263-7
pubmed: 23615608
BMC Cancer. 2021 Mar 7;21(1):241
pubmed: 33678155
Cancer Res. 2007 Feb 1;67(3):1030-7
pubmed: 17283135
Nat Rev Mol Cell Biol. 2004 Jan;5(1):45-54
pubmed: 14708009
World J Clin Oncol. 2020 Mar 24;11(3):121-135
pubmed: 32257843
PLoS One. 2011;6(6):e20473
pubmed: 21673810
Cancers (Basel). 2021 Sep 16;13(18):
pubmed: 34572863
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9385-90
pubmed: 19458257
Trends Genet. 2013 Jul;29(7):427-37
pubmed: 23453622
Sci Rep. 2017 Jan 23;7:40983
pubmed: 28112190
Curr Biol. 2007 Mar 6;17(5):431-7
pubmed: 17320392
Oncotarget. 2016 Sep 20;7(38):60793-60806
pubmed: 27563823
Oncol Lett. 2018 Apr;15(4):4900-4906
pubmed: 29552128
Cancer Res. 2000 May 1;60(9):2512-9
pubmed: 10811133

Auteurs

Thomas Dittmar (T)

Institute of Immunology, Center for Biomedical Education and Research (ZBAF), University of Witten/Herdecke, Stockumer Str. 10, 58448 Witten, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH